Aurora Cannabis (TSE:ACB – Get Free Report) has been given a C$9.00 price target by TD Securities in a note issued to investors on Wednesday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. TD Securities’ price target would indicate a potential upside of 46.10% from the company’s previous close.
Aurora Cannabis Stock Down 0.3 %
Shares of ACB traded down C$0.02 during mid-day trading on Wednesday, reaching C$6.16. The company’s stock had a trading volume of 290,705 shares, compared to its average volume of 1,004,979. The business has a fifty day moving average of C$7.04 and a 200 day moving average of C$7.65. The company has a market cap of C$336.71 million, a price-to-earnings ratio of -9.78 and a beta of 2.71. Aurora Cannabis has a 1 year low of C$3.84 and a 1 year high of C$12.85. The company has a quick ratio of 2.48, a current ratio of 3.76 and a debt-to-equity ratio of 16.95.
Insider Activity
In other news, Senior Officer Andre Jerome sold 7,712 shares of the company’s stock in a transaction on Monday, September 23rd. The shares were sold at an average price of C$7.70, for a total value of C$59,382.40.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.
Featured Stories
- Five stocks we like better than Aurora Cannabis
- 3 Warren Buffett Stocks to Buy Now
- The Great CPU Race: AMD and Intel Battle for Dominance
- 10 Best Airline Stocks to Buy
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Top Biotech Stocks: Exploring Innovation Opportunities
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.